Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables

Drug and Alcohol Dependence

Volumn 105, Issue 1-2, 2009, Pages 48-55

  Dean, Andy C ^a   London, Edythe D ^a,b   Sugar, Catherine A ^c   Kitchen, Christina M R ^c   Swanson, Aimee Noelle ^b   Heinzerling, Keith G ^b   Kalechstein, Ari D ^a   Shoptaw, Steven ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Abstinence; Cognitive; Methamphetamine; Neuropsychology; Outcome; Prediction; Predictors; Relapse; Retention; Treatment

Indexed keywords

AMFEBUTAMONE; METHAMPHETAMINE;

ADULT; ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; DRUG DEPENDENCE; DRUG USE; EMPLOYMENT; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; MOOD; NONPARAMETRIC TEST; OUTCOME ASSESSMENT; OUTPATIENT CARE; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; RESPONSE TIME; SOCIAL ENVIRONMENT; TOBACCO DEPENDENCE; TREATMENT OUTCOME; URINALYSIS; WORKING MEMORY;

ADULT; AFFECT; AMPHETAMINE-RELATED DISORDERS; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; COGNITIVE THERAPY; CRIME; FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; METHAMPHETAMINE; NEUROPSYCHOLOGICAL TESTS; PATIENT COMPLIANCE; PREDICTIVE VALUE OF TESTS; REACTION TIME; SMOKING; SOCIAL ENVIRONMENT; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME;

EID: 69949087349     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2009.06.008     Document Type: Article

References (39)

1. Aharonovich E., Hasin D.S., Brooks A.C., Liu X., Bisaga A., and Nunes E.V. Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend. 81 (2006) 313-322
2. Aharonovich E., Nunes E., and Hasin D. Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment. Drug Alcohol Depend. 71 (2003) 207-211
3. Association A.P. Diagnostic and Statistical Manual of Mental Disorders. Fourth ed., Text Revision (2000), American Psychiatric Association, Washington, DC
4. Beck A.T., Steer R.A., and Brown G.K. BDI-II Manual (1996), The Psychological Corporation, San Antonio
5. Brecht M.L., Greenwell L., and Anglin M.D. Methamphetamine treatment: trends and predictors of retention and completion in a large state treatment system (1992-2002). J. Subst. Abuse. Treat. 29 (2005) 295-306
6. Brecht M.L., Greenwell L., von Mayrhauser C., and Anglin M.D. Two-year outcomes of treatment for methamphetamine use. J. Psychoactive Drugs Suppl. 3 (2006) 415-426
7. Brecht M.L., von Mayrhauser C., and Anglin M.D. Predictors of relapse after treatment for methamphetamine use. J. Psychoactive Drugs 32 (2000) 211-220
8. Breiman L., Friedman J.H., Olshen R.A., and Stone C.J. Classification and Regression Trees (1984), Wadsworth, Belmont, CA
9. Derogatis L.R., and Melisaratos N. The brief symptom inventory: an introductory report. Psychol. Med. 13 (1983) 595-605
10. Fagerstrom K.O. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict. Behav. 3 (1978) 235-241
11. Gonzalez R., Rippeth J.D., Carey C.L., Heaton R.K., Moore D.J., Schweinsburg B.C., Cherner M., and Grant I. Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure. Drug Alcohol Depend. 76 (2004) 181-190
12. Hardy D.J., and Hinkin C.H. Reaction time performance in adults with HIV/AIDS. J. Clin. Exp. Neuropsychol. 24 (2002) 912-929
13. Hartz D.T., Frederick-Osborne S.L., and Galloway G.P. Craving predicts use during treatment for methamphetamine dependence: a prospective, repeated-measures, within-subject analysis. Drug Alcohol Depend. 63 (2001) 269-276
14. Heatherton T.F., Kozlowski L.T., Frecker R.C., and Fagerstrom K.O. The Fagerstrom Test for Nicotine Dependence: A revision of the Fagerstrom Tolerance Questionnaire. British J. Addict. 86 (1991) 1119-1127
15. Hillhouse M.P., Marinelli-Casey P., Gonzales R., Ang A., and Rawson R.A. Predicting in-treatment performance and post-treatment outcomes in methamphetamine users. Addiction 102 Suppl. 1 (2007) 84-95
16. Hoffman W.F., Moore M., Templin R., McFarland B., Hitzemann R.J., and Mitchell S.H. Neuropsychological function and delay discounting in methamphetamine-dependent individuals. Psychopharmacology (Berl) 188 (2006) 162-170
17. Hser Y.I., Evans E., and Huang Y.C. Treatment outcomes among women and men methamphetamine abusers in California. J. Subst. Abuse Treat. 28 (2005) 77-85
18. Kalechstein A.D., Newton T.F., and Green M. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. Neurophysiol. Clin. 15 (2003) 215-220
19. Kaplan R.M., Sieber W.J., and Ganiats T.G. The quality of well-being scale: comparison of the interviewer-administered version with a self-administered questionnaire. Psychol. Health 12 (1997) 783-791
20. Lee N.K., and Rawson R.A. A systematic review of cognitive and behavioural therapies for methamphetamine dependence. Drug Alcohol Rev. 27 (2008) 309-317
21. Maglione M., Chao B., and Anglin D. Residential treatment of methamphetamine users: correlates of drop-out from the California alcohol and drug data system (CADDS). Addict. Res. 8 (2000) 65-79
22. Maglione M., Chao B., and Anglin M.D. Correlates of outpatient drug treatment drop-out among methamphetamine users. J. Psychoactive Drugs 32 (2000) 221-228
23. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., Pettinati H., and Argeriou M. The fifth edition of the Addiction Severity Index. J. Subst. Abuse. Treat. 9 (1992) 199-213
24. Mendrek A., Monterosso J.R., Simon S.L., Jarvik M., Brody A.L., Olmstead R., Domier C., Cohen M.S., Ernst M., and London E.D. Working memory in cigarette smokers: comparison to non-smokers and effects of abstinence (2005)
25. Monterosso J.R., Aron A.R., Cordova X., Xu J., and London E.D. Deficits in response inhibition associated with chronic methamphetamine abuse. Drug Alcohol Depend. 79 (2005) 273-277
26. Newton T.F., Kalechstein A.D., Hardy D.J., Cook I.A., Nestor L., Ling W., and Leuchter A.F. Association between quantitative EEG and neurocognition in methamphetamine-dependent volunteers. Clin. Neurophysiol. 115 (2004) 194-198
27. Peterson J.D., Wolf M.E., and White F.J. Repeated amphetamine administration decreases D1 dopamine receptor-mediated inhibition of voltage-gated sodium currents in the prefrontal cortex. J. Neurosci. 26 (2006) 3164-3168
28. Rawson R., McCann M., Huber A., Shoptaw S., Higgins S.T., and Silverman K. Motivating behavior change among illicit-drug abusers: Research on contingency management interventions. Contingency Management and Relapse Prevention as Stimulant Abuse Treatment Interventions (1999), American Psychological Association, Washington, DC, US pp. 57-74
29. Salo R., Nordahl T.E., Natsuaki Y., Leamon M.H., Galloway G.P., Waters C., Moore C.D., and Buonocore M.H. Attentional control and brain metabolite levels in methamphetamine abusers. Biol. Psychiatry 61 (2007) 1272-1280
30. Salo R., Nordahl T.E., Possin K., Leamon M., Gibson D.R., Galloway G.P., Flynn N.M., Henik A., Pfefferbaum A., and Sullivan E.V. Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals. Psychiatry Res. 111 (2002) 65-74
31. Scott J.C., Woods S.P., Matt G.E., Meyer R.A., Heaton R.K., Atkinson J.H., and Grant I. Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol. Rev. 17 (2007) 275-297
32. Shoptaw S., Heinzerling K.G., Rotheram-Fuller E., Steward T., Wang J., Swanson A.N., De La Garza R., Newton T., and Ling W. Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend. 96 (2008) 222-232
33. Simon, S.L., Dean, A.C., Cordova, X., Monterosso, J.R., London, E.D., in review. Methamphetamine dependence and neuropsychological functioning: Evaluating change during early abstinence. Psychology of Addictive Behavior.
34. Simon S.L., Domier C., Sim T., Richardson K., Rawson R.A., Huber A., and Ling W. Cognitive correlates of chronic methamphetamine use. Drug Alcohol Depend. 60 (2000) 511
35. Smith E.E., Jonides J., and Koeppe R.A. Dissociating verbal and spatial working memory using PET. Cerebral Cortex 6 (1996) 11-20
36. Sobell M.B., Sobell L.C., Klajner F., Pavan D., and Basian E. The reliability of a timeline method for assessing normal drinker college students' recent drinking history: utility for alcohol research. Addict. Behav. 11 (1986) 149-161
37. Verdejo-Garcia A., Bechara A., Recknor E.C., and Perez-Garcia M. Executive dysfunction in substance dependent individuals during drug use and abstinence: an examination of the behavioral, cognitive and emotional correlates of addiction. J. Int. Neuropsychol. Soc. 12 (2006) 405-415
38. Woods S.P., Rippeth J.D., Conover E., Gongvatana A., Gonzalez R., Carey C.L., Cherner M., Heaton R.K., and Grant I. Deficient strategic control of verbal encoding and retrieval in individuals with methamphetamine dependence. Neuropsychology 19 (2005) 35-43
39. Xu J., Mendrek A., Cohen M.S., Monterosso J., Rodriguez P., Simon S.L., Brody A., Jarvik M., Domier C.P., Olmstead R., Ernst M., and London E.D. Brain activity in cigarette smokers performing a working memory task: effect of smoking abstinence. Biol. Psychiatry 58 (2005) 143-150